Zhejiang Wolwo Bio-Pharmaceutical Co (SZSE:300357) Total Liabilities : ¥145.1 Mil (As of Mar. 2025)

View and export this data going back to 2014. Start your Free Trial

What is Zhejiang Wolwo Bio-Pharmaceutical Co Total Liabilities?

Zhejiang Wolwo Bio-Pharmaceutical Co's Total Liabilities for the quarter that ended in Mar. 2025 was ¥145.1 Mil.

Zhejiang Wolwo Bio-Pharmaceutical Co's quarterly Total Liabilities increased from Sep. 2024 (¥231.71 Mil) to Dec. 2024 (¥250.30 Mil) but then declined from Dec. 2024 (¥250.30 Mil) to Mar. 2025 (¥145.13 Mil).

Zhejiang Wolwo Bio-Pharmaceutical Co's annual Total Liabilities increased from Dec. 2022 (¥170.76 Mil) to Dec. 2023 (¥258.46 Mil) but then declined from Dec. 2023 (¥258.46 Mil) to Dec. 2024 (¥250.30 Mil).

Zhejiang Wolwo Bio-Pharmaceutical Co Total Liabilities Historical Data

The historical data trend for Zhejiang Wolwo Bio-Pharmaceutical Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Wolwo Bio-Pharmaceutical Co Total Liabilities Chart

Zhejiang Wolwo Bio-Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Liabilities

Get a 7-Day Free Trial

86.42

135.36

170.76

258.46

250.30

Zhejiang Wolwo Bio-Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Liabilities	Get a 7-Day Free Trial															241.17	326.77	231.71	250.30	145.13

Zhejiang Wolwo Bio-Pharmaceutical Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Zhejiang Wolwo Bio-Pharmaceutical Co's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	182.583	+	(7.93	+	59.782
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	250.3

Total Liabilities	=	Total Assets (A: Dec. 2024 )	-	Total Equity (A: Dec. 2024 )
	=	2709.125	-	2458.83
	=	250.3

Zhejiang Wolwo Bio-Pharmaceutical Co's Total Liabilities for the quarter that ended in Mar. 2025 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	84.486	+	(1.374	+	59.269
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	145.1

Total Liabilities	=	Total Assets (Q: Mar. 2025 )	-	Total Equity (Q: Mar. 2025 )
	=	2675.508	-	2530.38
	=	145.1

Zhejiang Wolwo Bio-Pharmaceutical Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Zhejiang Wolwo Bio-Pharmaceutical Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhejiang Wolwo Bio-Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Wolwo Bio-Pharmaceutical Co Ltd (SZSE:300357) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 636 Zhiyuan North Road, Wukang Town, Deqing County, Zhejiang Province, Huzhou, CHN, 313299

Website

http://www.wolwobiotech.com

Zhejiang Wolwo Bio-Pharmaceutical Co Ltd is a Chinese bio-pharmaceutical company. It is engaged in the research development, production and sales of allergic diseases diagnosis and treatment products. The product portfolio of the company covers dust mites drops, dust mites skin prick diagnosis kit, silk, and others.

Executives

Hu Geng Xi	Directors, executives
Zhang Lu	Directors, executives
Wang Li Hong	Directors, executives
	Director
Li Qin	Supervisors
Wang Xin Hua	Secretary, Director
Li Xiao Nan	Supervisors

Zhejiang Wolwo Bio-Pharmaceutical Co Headlines

No Headlines